Address: |
2218 Kausen Dr., Suite 130 Elk Grove, CA 95758 Ph: 916-683-8774 Fax: 916-683-8777
|
Education: |
- University of Massachusetts
Medical School Fellowship in Nephrology Worcester, MA July 2005 - June 2007
- University of Massachusetts Medical School Chief Resident,
Internal Medicine Residency Program Worcester, MA July 2004 - June 2005
- University of Massachusetts Medical School Categorical,
Internal Medicine Residency Program Worcester, MA July 2001 - June 2004
- St. George's University School of Medicine
Medical Doctorate Degree Grenada, WI / Bay Shore, NY August 1997 - June 2001
- University of California, Los Angeles
Bachelor of Science Psychology Los Angeles, CA Sept 1991 - June 1995
|
Certifications / Licensure / Work Experience: |
- American Board of Internal Medicine,
Board Eligible in Nephrology July 2007
- American Board of Internal Medicine Certification
August 2005 - Devember 2015
- Massachusetts Medical Licensure
March 2005 - 2007
|
Professional Societies: |
- National Kidney Foundation
2006 - Present
- American Society of Nephrology
2006 - Present
- Renal Physicians Associations
2006 - Present
- Massachusetts Medical Society,
Resident Physicians Fellowship appointed Communications Committee Representative 2003 - 2004
- Massachusetts Medical Society
2001 - Present
- American College of Physicians, American Society of Internal Medicine
2001 - Present
|
Teaching Experience: |
- University of Massachusetts Medical School
3rd Year Medical Student Renal Lecture Series: Acute Renal Failure 2006 - 2007
- University of Massachusetts Graduate School of Nursing,
Worcester, MA Renal Lecure Series: Acute Renal Failure 2006 - 2007
- University of Massachusetts Medical School,
Dept. of Medicine, Resident Noon Conference: Neflhrolithiasis August 2006
- University of Massachusetts Medical School,
Worcester, MA Clinical Instructor 2005 - Present
- University of Massachusetts Medical School, Worcester, MA Chief Resident Conducted Morning Reports and Noon Conferences Involved in Administrative Duties Within the Department of Medicine
2005 - 2006
- University of Massachusettes Medical School,
Worecester, MA Physical Diagnosis Instructor for Second Year Medical Students 2005 - 2006
|
Research: |
- Pleiotropic Effects of Starins in Patients with Hypertension and Microalbuminuria.
Under John Danziger, M.D., Division of Renal Medicine. Massachusetts Medical Center, Worcester, MA (Under IRB Review) 2006 - 2007
- Study of Cox-2 Expression
Division of Renal Medicine Brookdale University Hospital, Brooklyn, NY Performed Immunohistochemical Studies and Nephrectomies 2000 - 2001
- Lab Assistant / Researcher
Division of Pediatric Hematology / Oncology University of California, Los Angeles Medical Center Studied Various Aspect of Ofn-Myc Expression in Neuroblastoma 1992 - 1995
|
Publications: |
- Wada, RK; Pai, DS; Huang, J; Yamashiro, JM; Sidell, N: "Interferon-Gamma and Retinoic Acid Down Regulate N-myc in Neuroblastoma Through Complimentary Mechanism of Action" Cancer Letter 1997 Dec 23; 121(2):181-8
- Goodman, LA; Lui, BC; Thiele, CJ; Schmidy, ML; Cohn, SL; Yamashiro, JM; Pai, DS; Ikegaki, N; Wada, RKl "Modulation of N-myc Expression Alters the Invasiveness of Neuroblastoma" Clinical Experimental Metastasis. 1997 Mar; 15(2) 130-9
- Woodruff, KA; "Cell Type Specific Activity of the N-myc Promoter in the Human Neuroblastoma Cells is Mediated by a Down Stream Silencer" Oncofene 1995 Apr 6; 10(7): 1335-41
|
Honors and Awards: |
- Iota Epsilon Alpha Honor Society Member, St. Gorge's University School of Medicine, 1997 - 2001
- Dean's List, St. George's University School of Medicine, 1997 - 2001
- Geoffery Boune Scholarship Recipient, St. George's University, School of Medicine
|
Selected Clinical Trials: |
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Trial Evaluating the Efficacy and Safety of XXX in Adult Patiets on Chronic Haemodialysis.
A Phase III, Randomized, Active-Controlled, Open-Label, Multi-Center Study of the Safety and Efficacy of XXX Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with Epogen.
A Phase IV, Long Term, Observational Safety Study in End Stage Renal Disease Subjects Treated with XXX.
A Phase II, Randomized Double-Blind, Placebo-Controlled, Multi-Center, to Evaluate the Safety and Efficacy of XXX in Patients with Nephropaty Due to Type 2 Diabetes.
Patient Focus Group for Qualatative Assessment of Anemia Associated with Chronic Kidney Disease.
A Multicenter, Randomized, Double-Blink Study to Evaluate the Efficacy and Safety of XXX in Patients with Type 2 Diabetes Mellitus and End Stage Renal Disease Who Are on Dialysis and Who Have Inadequate Glycemic Control.
A Phase II Study of the Safety and Efficacy of XXX Injection for the Maintenace Treatment of Anemia in Subjects with Chronic Renal Failure on Hemodialysis, of Do Not Requre Dialysis and Previously Treated with Darbepoetin Alfa.
|
Certificate of Completion: |
The National Institutes of Heath (NIH) Office of Extramural Research Certifies that Dr. Pai Successfully Completed the NIH Web-Based Training Course "Protecting Human Research Participants" 07-01-2009. Certification Number 250174.
|